Schedule 13G ownership disclosure

APRICUS BIOSCIENCES INC

Security class unavailable · CUSIP: 03832V307

Event date: 2017-06-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
415,441
Percent of class
3.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000930413-17-002335
Form type
SC 13G
Filer
SEELOS THERAPEUTICS, INC.
CIK
CIK 1017491
Filed
Jun 16, 2017
Reporting period
Jun 08, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub